KYORIN Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3247090008
JPY
1,498.00
6 (0.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,30,087.00
1,19,532.00
1,13,270.00
1,05,534.00
1,02,904.00
1,09,983.00
1,13,620.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,30,087.00
1,19,532.00
1,13,270.00
1,05,534.00
1,02,904.00
1,09,983.00
1,13,620.00
Raw Material Cost
70,573.00
67,912.00
63,106.00
56,097.00
51,288.00
52,965.00
56,224.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
173.00
66.00
66.00
66.00
68.00
75.00
64.00
Selling and Distribution Expenses
36,453.00
37,375.00
34,140.00
35,536.00
36,138.00
38,541.00
37,646.00
Other Expenses
1,034.10
795.30
1,083.70
883.10
963.50
1,091.20
1,072.60
Total Expenditure (Excl Depreciation)
1,17,540.00
1,13,306.00
1,08,149.00
1,00,530.00
97,129.00
1,02,493.00
1,04,660.00
Operating Profit (PBDIT) excl Other Income
12547
6226
5121
5004
5775
7490
8960
Other Income
718.00
1,867.00
839.00
598.00
1,571.00
840.00
465.00
Operating Profit (PBDIT)
17,868.00
12,383.00
9,800.00
9,316.00
10,910.00
11,551.00
12,365.00
Interest
173.00
66.00
66.00
66.00
68.00
75.00
64.00
Exceptional Items
-319.00
-788.00
1,016.00
-320.00
1,073.00
0.00
0.00
Gross Profit (PBDT)
59,514.00
51,620.00
50,164.00
49,437.00
51,616.00
57,018.00
57,396.00
Depreciation
4,603.00
4,290.00
3,840.00
3,714.00
3,564.00
3,221.00
2,940.00
Profit Before Tax
12,770.00
7,239.00
6,906.00
5,216.00
8,352.00
8,255.00
9,359.00
Tax
3,684.00
1,764.00
2,182.00
1,284.00
2,222.00
2,106.00
2,490.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
9,086.00
5,475.00
4,723.00
3,932.00
6,130.00
6,149.00
6,869.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
9,086.00
5,475.00
4,723.00
3,932.00
6,130.00
6,149.00
6,869.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
9,086.00
5,475.00
4,723.00
3,932.00
6,130.00
6,149.00
6,869.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,36,285.00
1,30,735.00
1,25,461.00
1,24,507.00
1,24,661.00
1,22,710.00
1,23,395.00
Earnings per share (EPS)
158.16
95.4
82.42
68.62
106.99
107.34
104.68
Diluted Earnings per share
158.16
95.4
82.42
68.62
106.99
107.34
104.68
Operating Profit Margin (Excl OI)
9.65%
5.21%
4.52%
4.74%
5.61%
6.81%
7.89%
Gross Profit Margin
13.35%
9.65%
9.49%
8.46%
11.58%
10.43%
10.82%
PAT Margin
6.98%
4.58%
4.17%
3.73%
5.96%
5.59%
6.05%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 8.83% vs 5.53% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 65.95% vs 15.92% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 63.08% vs 17.35% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 162.12% vs 0.00% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of KYORIN Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
1,30,087.00
28,835.00
1,01,252.00
351.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,30,087.00
28,835.00
1,01,252.00
351.14%
Raw Material Cost
70,573.00
10,707.00
59,866.00
559.13%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
173.00
777.00
-604.00
-77.73%
Selling and Distribution Expenses
36,453.00
11,676.00
24,777.00
212.20%
Other Expenses
1,034.10
1,103.90
-69.80
-6.32%
Total Expenditure (Excl Depreciation)
1,17,540.00
34,199.00
83,341.00
243.69%
Operating Profit (PBDIT) excl Other Income
12,547.00
-5,364.00
17,911.00
333.91%
Other Income
718.00
2,688.00
-1,970.00
-73.29%
Operating Profit (PBDIT)
17,868.00
1,308.00
16,560.00
1,266.06%
Interest
173.00
777.00
-604.00
-77.73%
Exceptional Items
-319.00
-1,209.00
890.00
73.61%
Gross Profit (PBDT)
59,514.00
18,128.00
41,386.00
228.30%
Depreciation
4,603.00
3,984.00
619.00
15.54%
Profit Before Tax
12,770.00
-4,662.00
17,432.00
373.92%
Tax
3,684.00
176.00
3,508.00
1,993.18%
Provisions and contingencies
0
0
0.00
Profit After Tax
9,086.00
-4,838.00
13,924.00
287.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
9,086.00
-4,838.00
13,924.00
287.80%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
9,086.00
-4,838.00
13,924.00
287.80%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,36,285.00
68,518.00
67,767.00
98.90%
Earnings per share (EPS)
158.16
-53.92
212.08
393.32%
Diluted Earnings per share
158.16
-53.92
212.08
393.32%
Operating Profit Margin (Excl OI)
9.65%
-18.60%
0.00
28.25%
Gross Profit Margin
13.35%
-2.35%
0.00
15.70%
PAT Margin
6.98%
-16.78%
0.00
23.76%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 13,008.70 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 8.83% vs 5.53% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 908.60 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 65.95% vs 15.92% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,715.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 63.08% vs 17.35% in Mar 2024

Annual - Interest
Interest 17.30 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 162.12% vs 0.00% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.65%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024